| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/12/2006 | CN1250295C Magnetism and drug combined type fragrant baldric for avoiding plague |
| 04/12/2006 | CN1250291C Stabilised pharmaceutical compositions and process for their preparation comprising antibiotic and expectorant |
| 04/12/2006 | CN1250285C Cellular vesicle called 'exosome', prepn. and use thereof in immune stimulation |
| 04/12/2006 | CN1250284C Hepatitis A inactivated vaccine |
| 04/12/2006 | CN1250283C Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 04/12/2006 | CN1250282C Stable protein compositions |
| 04/12/2006 | CN1250272C Traditional Chinese medicine preparation for treating lung disease |
| 04/12/2006 | CN1250258C Usage of one-ingredient fleur root high wine soak liquid |
| 04/12/2006 | CN1250257C Granule for clearing away the lung-heat and removing poison |
| 04/12/2006 | CN1250240C Isatis root extract, and preparing method and use thereof |
| 04/12/2006 | CN1250238C Application of eupatorium for preparing medicine to prevent and treat serious acute respiratory syndrome (SARS) |
| 04/12/2006 | CN1250232C Lactic acid bacteria and bifidobacteria, composition containing them and its use |
| 04/12/2006 | CN1250223C Pyrrolo-triazine and pyrimidine compounds |
| 04/12/2006 | CN1250219C Pharmaceutical composition |
| 04/12/2006 | CN1250216C Medication for treating acute hepatitis and chronic hepatitis and preparation technique |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026487 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity |
| 04/11/2006 | US7026485 inhibitors of HIV protease; N-heterocyclic moiety containing hydroxyethylamine compounds where the heterocyclic moiety may be octahydroisoquinoline |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026469 Compositions and methods of double-targeting virus infections and cancer cells |
| 04/11/2006 | US7026457 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 04/11/2006 | US7026443 Composition including an oligopeptide 13 residues or less in length, which comprises the sequence ATLERTEVY (SEQ ID NO:31040); use in epitope-based vaccines |
| 04/11/2006 | US7026349 Sulfonamides |
| 04/11/2006 | US7026348 Antiinflammatory agents; sepsis shock; rheumatic diseases |
| 04/11/2006 | US7026337 Gel formulations of hydroxypyridone derivatives, which contain solvents and hydrophilic gel-forming agents make possible a high release of the active compound |
| 04/11/2006 | US7026335 Melanocortin receptor ligands |
| 04/11/2006 | US7026331 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 04/11/2006 | US7026326 Substituted heterocyclic compounds and methods of use |
| 04/11/2006 | US7026322 Anticancer agents; fungicides |
| 04/11/2006 | US7026316 (optionally aza)cycloalkyl-N,N-optionally thia-, oxothia- or dioxothia-)alkyleneglycine derivatives, e.g., N-{4-[(1S)-1-amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl}-N'-hexylureA; especially treating type 2 diabetes |
| 04/11/2006 | US7026311 Dibenzodiazepine derivatives, their preparation and use |
| 04/11/2006 | US7026300 One step immunization procedure for inducing a Chlamydia specific immune response |
| 04/11/2006 | US7026288 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
| 04/11/2006 | US7026270 malayamycin A and desmethylmalayamycin A prepared from a previously unknown strain of Streptomyces malaysiensis, used for combating or controlling phytopathogenic fungi |
| 04/11/2006 | US7026161 Lactobacillus sp. strain and use thereof |
| 04/11/2006 | US7026157 Bacterial hemoglobin receptor genes |
| 04/11/2006 | US7026136 compounds that inhibit activity of the AcrAB or AcrAB-like efflux pump are identified as compounds which reduce antibiotic resistance in a microbe that has 2 chromosomal mutations in a gene encoding an antibiotic target that renders it resistant and increased expression of at least one efflux pump |
| 04/11/2006 | US7026130 screening chemical compounds for ability to compete with hepatitis C virus for binding to a HCV receptor by comparing the binding of the HCV receptor to the E2 protein of HCV in the presence of said compound to the binding of the receptor to the protein in the absence of the compound |
| 04/11/2006 | US7026113 Veterinary medicine; vaccine containing mutant gene |
| 04/11/2006 | US7025993 Herbal composition PHY906 and its use in chemotherapy |
| 04/11/2006 | US7025983 Water soluble film forming polymer |
| 04/11/2006 | US7025968 Identifying viricidal agents which prevent cytomegalo viral infection and distribution; gene expression inhibition |
| 04/11/2006 | US7025958 Eyes, ears, nose, throat; ethylene oxide-propylene oxide copolymer microbiocide |
| 04/11/2006 | CA2274530C Process for producing 5-arylthio imidazole derivatives |
| 04/06/2006 | WO2006036131A1 A novel compound and a novel microorganism for producing the novel compound |
| 04/06/2006 | WO2006036031A1 Fused furan derivative and use thereof |
| 04/06/2006 | WO2006035974A1 Oligoribonucleotide |
| 04/06/2006 | WO2006035939A1 Immune stimulating oligonucleotide and use thereof in pharmaceutical |
| 04/06/2006 | WO2006035681A1 HLA-A11-RESTRICTED Tax ANTITUMOR EPITOPES |
| 04/06/2006 | WO2006035291A1 Crystalline forms of cefdinir potassium |
| 04/06/2006 | WO2006035283A1 Oxazolidinone derivatives as antimicrobials |
| 04/06/2006 | WO2006035084A1 Gene construction, vector and dna vaccine for the vaccination of aquatic animals |
| 04/06/2006 | WO2006035082A1 Mutant g genes of the trout viral haemorrhagic septicaemia virus (vhsv) and applications thereof |
| 04/06/2006 | WO2006035069A1 Hiv inhibiting 5-substituted pyrimidines |
| 04/06/2006 | WO2006035061A1 Hcv inhibiting bi-cyclic pyrimidines |
| 04/06/2006 | WO2006034873A1 METHODS FOR THE GENERATION OF HEPATOCYTE-LIKE CELLS FROM HUMAN BLASTOCYST-DERIVED STEM (hBs) |
| 04/06/2006 | WO2006034560A2 Prevention and treatment of mycoplasma-associated diseases |
| 04/06/2006 | WO2006007384A3 Antibiotics containing borinic acid complexes and methods of use |
| 04/06/2006 | WO2004076621A3 Compositions of nucleic acids for treating and detecting influenza virus |
| 04/06/2006 | US20060074377 Microprojection array immunization patch and method |
| 04/06/2006 | US20060074244 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 04/06/2006 | US20060074129 Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074107 Pharmaceutically active piperidine derivatives |
| 04/06/2006 | US20060074106 Treatment of inflammatory disorders |
| 04/06/2006 | US20060074095 Novel purine derivatives, preparation method and use as medicines |
| 04/06/2006 | US20060074065 compounds enhance the activity of beta-lactam antibiotics; use to treat antibiotic resistance bacterial infections like otitis, sinusitis, meningitis etc. especially associated with Enterobacter, Citrobacter, and Serratia; Diphenylmethyl 7-phenylacetamido-3-(trifluorosulfonyloxy)-3-cephem-4-carboxylate |
| 04/06/2006 | US20060074064 Tricyclic 6-alkylidene-penems as beta-lactamase inhibitors |
| 04/06/2006 | US20060074053 Ophthalmic solution containing quinolone antimicrobial compound |
| 04/06/2006 | US20060074037 Producing/evaluating a protein/polypeptide (alpha-defensin) with increased antimicrobial activity and stability to effect chemotaxis of T-cells, neutrophil recruitment, or cytokine or interleukin-8 release; immunostimulants; respiratory system disorders; inflammatory bowel disease; viricides; cancer; HIV |
| 04/06/2006 | US20060073191 B-1, 4-mannobiose-containing composition |
| 04/06/2006 | US20060073169 Acellular antibordetella vaccine |
| 04/06/2006 | US20060073167 Vaccine for fish cold-water disease |
| 04/06/2006 | US20060073166 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR |
| 04/06/2006 | US20060073164 Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 04/06/2006 | US20060073162 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 04/06/2006 | US20060073156 Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract |
| 04/06/2006 | US20060073145 Methods and compositions for inhibiting CD14 mediated cell activation |
| 04/06/2006 | US20060073123 Adenovirus vectors for immunotherapy |
| 04/06/2006 | US20060073114 Compounds and methods to inhibit or augment an inflammatory response |
| 04/06/2006 | DE10231370B4 Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Thiophenglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
| 04/06/2006 | DE102004049008A1 Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur New uses for α-agonists with 2-imidazoline |
| 04/06/2006 | DE102004046990A1 Pharmazeutischer Wirkstoff zur Stärkung des Immunsystems Active pharmaceutical ingredient for boosting the immune system |
| 04/06/2006 | DE102004045758A1 Pharmazeutischer Wirkstoff gegen das HIV-Syndrom Active pharmaceutical ingredient against the HIV syndrome |
| 04/06/2006 | DE102004034493A1 Pharmaceutical and/or cosmetic preparations, useful to treat e.g. skin, gastro-intestinal and infectious disease, comprising an extract from Quercus coccifera root and optionally an auxiliary or additives |
| 04/06/2006 | CA2824308A1 Targeting opposite strand replication intermediates of single-stranded viruses by rnai |
| 04/06/2006 | CA2581606A1 Carrier-free composition for the treatment of onychomycosis |
| 04/06/2006 | CA2580798A1 Methods for the generation of hepatocyte-like cells from human blastocyst-derived stem (hbs) |
| 04/06/2006 | CA2577467A1 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 04/06/2006 | CA2575472A1 Hiv inhibiting 5-substituted pyrimidines |
| 04/06/2006 | CA2573976A1 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 04/05/2006 | EP1642987A2 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses |
| 04/05/2006 | EP1642975A2 Chemokine receptors 88-2B (CKR-3) and their antibodies |
| 04/05/2006 | EP1642974A1 Recombinant soluble Fc receptors |
| 04/05/2006 | EP1642973A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642972A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642901A1 Novel erythromycin derivatives |
| 04/05/2006 | EP1642596A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/05/2006 | EP1642591A1 MEDICINAL COMPOSITION CONTAINING NF-kAPPA B DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME |
| 04/05/2006 | EP1642582A1 Low dose entecavir formulation and use |